Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia

Journal of Infectious Diseases

Volumn 186, Issue 4, 2002, Pages 522-530

  Chrétien, Fabrice ^a,c   Lortholary, Olivier ^b   Kansau, Imad ^b   Neuville, Ségolène ^b   Gray, Françoise ^a   Dromer, Françoise ^b  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

^c FACULTÉ DE MÉDECINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FUNGEMIA; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MENINGOENCEPHALITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FUNGEMIA; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; MICE; MONOCYTES;

EID: 0037103623     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/341564     Document Type: Article

References (41)

1. Cryptococcosis
2. Epidemiology of cryptococcosis in France: 9-Year survey (1985-1993)
3. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome
4. Experimental model of intracerebral infection with Cryptococcus neoformans: Role of phagocytes and opsonization
5. Fungemia during murine cryptococcosis sheds some light on pathophysiology
6. Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection
7. Quantitative analysis of phagocytosis of Cryptococcus neoformans by adherent phagocytic cells by fluorescence multi-well plate reader
8. Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide
9. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages
10. Intracellular parasitism of macrophages by Cryptococcus neoformans
11. Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxyde synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide
12. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection
13. Leukocyte-facilitated entry of intracellular pathogens into the central nervous system
14. Human immunodeficiency virus (HIV)-infected human blood monocytes and peritoneal macrophages have reduced anticryprococcal activity whereas HIV-infected alveolar macrophages retain normal activity
15. Mechanisms of impaired anticryptococcal activity of monocytes from donors infected with human immunodeficiency virus
16. Monocyte dysfunction in patients with acquired immunodeficiency syndrome (AIDS) versus Cryptococcus neoformans
17. Human immunodeficiency virus type 1 envelope protein gp120 impairs intracellular antifungal mechanisms in human monocytes
18. Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: Role of the capsule
19. Effect of endothelial cells on phagocyte-mediated anticryptococcal activity
20. Molecular study on the interaction between the brain endothelial cells and C neoformans
21. Polysaccharide antigen in brain tissue of patient with AIDSs with cryptococcal meningitis
22. Pathology of cryptococcal meningoencephalitis: Analysis of 27 patients with pathogenetic implications
23. Histopathological studies on experimental cryptococcosis in nude mice
24. Studies on relationship between cysts and granulomas in murine cryptococcosis
25. Immune mediators in cerebrospinal fluid are influenced by meningeal involvement and human immunodeficiency virus serostatus during Cryptococcus neoformans infection
26. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat
27. The fine structure of cerebral fluid accumulation: Reactions of ependyma to implantation of cryptococcal polysaccharide
28. Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis
29. Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody
30. Cryptococcalcapsular polysaccharide clearance in nonimmune mice
31. In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: A critical role for tissue macrophages
32. Variants of a Cryptococcus neoformans strain elicit different inflammatory, responses in mice
33. Experimental murine pulmonary cryptococcosis: Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans
34. Histologic response to capsule-deficient Cryptococcus neoformans
35. What makes Cryptococcus neoformans a pathogen?
36. Cas1p is a membrane protein necessary for O-acetylation of the Cryptococcus neoformans capsular polysaccharide
37. Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection
38. In vitro and in vivo stability of a Cryptococcus neoformans glucuronoxylomannan epitope that elicits protective antibodies
39. Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans
40. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis
41. Cryptococcosis: Clinical and biological aspects